Pacira Historical Balance Sheet

PCRX Stock

USD 25.48 0.38 1.51%

Trend analysis of Pacira BioSciences, balance sheet accounts such as Other Liabilities of 24.9 M, Property Plant And Equipment Net of 283.7 M, Current Deferred Revenue of 41.1 M or Net Debt of 522.5 M provides information on Pacira BioSciences,'s total assets, liabilities, and equity, which is the actual value of Pacira BioSciences, to its prevalent stockholders. By breaking down trends over time using Pacira BioSciences, balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Pacira BioSciences, latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Pacira BioSciences, is a good buy for the upcoming year.

Pacira BioSciences, Inventory

126.01 Million

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pacira BioSciences,. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

For more information on how to buy Pacira Stock please use our How to Invest in Pacira BioSciences, guide.

About Pacira Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Pacira BioSciences, at a specified time, usually calculated after every quarter, six months, or one year. Pacira BioSciences, Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Pacira BioSciences, and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Pacira currently owns. An asset can also be divided into two categories, current and non-current.

Pacira BioSciences, Balance Sheet Chart

At this time, Pacira BioSciences,'s Liabilities And Stockholders Equity is fairly stable compared to the past year. Non Current Liabilities Total is likely to rise to about 732.8 M in 2025, whereas Other Current Liabilities is likely to drop slightly above 41.2 M in 2025.

Total Assets Other Current Liab Total Current Liabilities Total Stockholder Equity Accounts Payable Net Working Capital

Add Fundamental

Total Assets

Total assets refers to the total amount of Pacira BioSciences, assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Pacira BioSciences, books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Pacira BioSciences, balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Pacira BioSciences, are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Total Stockholder Equity

The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.

Accounts Payable

An accounting item on the balance sheet that represents Pacira BioSciences, obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Pacira BioSciences, are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.

Most accounts from Pacira BioSciences,'s balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Pacira BioSciences, current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pacira BioSciences,. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

For more information on how to buy Pacira Stock please use our How to Invest in Pacira BioSciences, guide.At this time, Pacira BioSciences,'s Liabilities And Stockholders Equity is fairly stable compared to the past year. Non Current Liabilities Total is likely to rise to about 732.8 M in 2025, whereas Other Current Liabilities is likely to drop slightly above 41.2 M in 2025.

	2022	2023	2024	2025 (projected)
Other Current Liabilities	80.7M	64.2M	73.9M	41.2M
Total Assets	1.7B	1.6B	1.8B	1.9B

Other Current Liab Total Assets

Pacira BioSciences, balance sheet Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Long Term Debt	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Common Stock Shares Outstanding	Short Term Investments	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross
Total Assets		0.84	0.61	0.97	0.78	0.99	0.46	0.95	0.43	0.63	0.62	0.98	0.84	0.45	0.97	0.74	0.97	0.61	0.68	0.32	0.98	0.95	0.86	0.83	0.97	0.93
Other Current Liab	0.84		0.82	0.73	0.82	0.82	0.3	0.79	0.18	0.51	0.77	0.77	0.85	0.68	0.79	0.9	0.72	0.66	0.69	0.41	0.8	0.73	0.65	0.83	0.89	0.64
Total Current Liabilities	0.61	0.82		0.42	0.76	0.55	0.1	0.51	0.05	0.1	0.89	0.52	0.78	0.65	0.5	0.78	0.43	0.41	0.39	0.15	0.54	0.47	0.51	0.49	0.74	0.35
Total Stockholder Equity	0.97	0.73	0.42		0.65	0.98	0.49	0.91	0.49	0.65	0.45	0.97	0.77	0.34	0.93	0.61	0.99	0.59	0.69	0.34	0.94	0.97	0.83	0.81	0.88	0.99
Other Liab	0.78	0.82	0.76	0.65		0.72	0.09	0.68	0.39	0.5	0.87	0.76	0.7	0.35	0.76	0.69	0.7	0.37	0.44	-0.06	0.78	0.68	0.72	0.64	0.86	0.61
Property Plant And Equipment Net	0.99	0.82	0.55	0.98	0.72		0.49	0.95	0.39	0.64	0.53	0.97	0.82	0.46	0.96	0.71	0.97	0.65	0.73	0.39	0.96	0.97	0.84	0.85	0.94	0.94
Current Deferred Revenue	0.46	0.3	0.1	0.49	0.09	0.49		0.52	-0.06	0.51	0.02	0.39	0.41	0.36	0.48	0.52	0.43	0.41	0.4	0.69	0.48	0.45	0.25	0.52	0.41	0.44
Net Debt	0.95	0.79	0.51	0.91	0.68	0.95	0.52		0.39	0.64	0.45	0.94	0.8	0.55	0.97	0.71	0.91	0.59	0.63	0.42	0.97	0.87	0.76	0.81	0.93	0.86
Retained Earnings	0.43	0.18	0.05	0.49	0.39	0.39	-0.06	0.39		0.18	0.11	0.55	0.4	0.1	0.39	-0.11	0.48	-0.25	-0.12	-0.39	0.41	0.39	0.47	0.04	0.34	0.53
Accounts Payable	0.63	0.51	0.1	0.65	0.5	0.64	0.51	0.64	0.18		0.21	0.6	0.34	0.13	0.69	0.51	0.65	0.4	0.52	0.45	0.68	0.66	0.37	0.73	0.57	0.62
Cash	0.62	0.77	0.89	0.45	0.87	0.53	0.02	0.45	0.11	0.21		0.55	0.65	0.35	0.55	0.73	0.49	0.41	0.42	-0.05	0.57	0.52	0.62	0.51	0.74	0.4
Non Current Assets Total	0.98	0.77	0.52	0.97	0.76	0.97	0.39	0.94	0.55	0.6	0.55		0.79	0.38	0.96	0.61	0.98	0.54	0.63	0.2	0.97	0.95	0.86	0.77	0.93	0.95
Non Currrent Assets Other	0.84	0.85	0.78	0.77	0.7	0.82	0.41	0.8	0.4	0.34	0.65	0.79		0.74	0.74	0.79	0.72	0.46	0.49	0.38	0.77	0.71	0.74	0.66	0.86	0.72
Other Assets	0.45	0.68	0.65	0.34	0.35	0.46	0.36	0.55	0.1	0.13	0.35	0.38	0.74		0.39	0.66	0.26	0.31	0.25	0.56	0.41	0.27	0.25	0.42	0.53	0.21
Long Term Debt	0.97	0.79	0.5	0.93	0.76	0.96	0.48	0.97	0.39	0.69	0.55	0.96	0.74	0.39		0.71	0.94	0.59	0.65	0.32	1.0	0.91	0.83	0.82	0.95	0.89
Cash And Short Term Investments	0.74	0.9	0.78	0.61	0.69	0.71	0.52	0.71	-0.11	0.51	0.73	0.61	0.79	0.66	0.71		0.58	0.66	0.63	0.61	0.72	0.62	0.56	0.79	0.82	0.52
Net Receivables	0.97	0.72	0.43	0.99	0.7	0.97	0.43	0.91	0.48	0.65	0.49	0.98	0.72	0.26	0.94	0.58		0.58	0.69	0.24	0.95	0.98	0.84	0.8	0.89	0.98
Common Stock Total Equity	0.61	0.66	0.41	0.59	0.37	0.65	0.41	0.59	-0.25	0.4	0.41	0.54	0.46	0.31	0.59	0.66	0.58		0.97	0.55	0.58	0.64	0.51	0.88	0.59	0.55
Common Stock Shares Outstanding	0.68	0.69	0.39	0.69	0.44	0.73	0.4	0.63	-0.12	0.52	0.42	0.63	0.49	0.25	0.65	0.63	0.69	0.97		0.5	0.64	0.75	0.58	0.92	0.63	0.66
Short Term Investments	0.32	0.41	0.15	0.34	-0.06	0.39	0.69	0.42	-0.39	0.45	-0.05	0.2	0.38	0.56	0.32	0.61	0.24	0.55	0.5		0.31	0.31	0.03	0.57	0.29	0.25
Non Current Liabilities Total	0.98	0.8	0.54	0.94	0.78	0.96	0.48	0.97	0.41	0.68	0.57	0.97	0.77	0.41	1.0	0.72	0.95	0.58	0.64	0.31		0.91	0.84	0.81	0.96	0.89
Inventory	0.95	0.73	0.47	0.97	0.68	0.97	0.45	0.87	0.39	0.66	0.52	0.95	0.71	0.27	0.91	0.62	0.98	0.64	0.75	0.31	0.91		0.82	0.83	0.87	0.96
Other Current Assets	0.86	0.65	0.51	0.83	0.72	0.84	0.25	0.76	0.47	0.37	0.62	0.86	0.74	0.25	0.83	0.56	0.84	0.51	0.58	0.03	0.84	0.82		0.64	0.83	0.84
Other Stockholder Equity	0.83	0.83	0.49	0.81	0.64	0.85	0.52	0.81	0.04	0.73	0.51	0.77	0.66	0.42	0.82	0.79	0.8	0.88	0.92	0.57	0.81	0.83	0.64		0.8	0.76
Total Liab	0.97	0.89	0.74	0.88	0.86	0.94	0.41	0.93	0.34	0.57	0.74	0.93	0.86	0.53	0.95	0.82	0.89	0.59	0.63	0.29	0.96	0.87	0.83	0.8		0.82
Property Plant And Equipment Gross	0.93	0.64	0.35	0.99	0.61	0.94	0.44	0.86	0.53	0.62	0.4	0.95	0.72	0.21	0.89	0.52	0.98	0.55	0.66	0.25	0.89	0.96	0.84	0.76	0.82

Click cells to compare fundamentals

Pacira BioSciences, Account Relationship Matchups

Pacira BioSciences, balance sheet Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	1.3B	2.1B	1.7B	1.6B	1.8B	1.9B
Other Current Liab	85.7M	127.6M	80.7M	64.2M	73.9M	41.2M
Total Current Liabilities	253.3M	521.1M	147.8M	97.4M	112.0M	123.5M
Total Stockholder Equity	619.7M	730.4M	775.0M	870.1M	1.0B	1.1B
Other Liab	21.5M	17.4M	77.6M	37.8M	43.5M	24.9M
Property Plant And Equipment Net	211.2M	264.8M	254.4M	234.9M	270.2M	283.7M
Net Debt	441.2M	543.3M	659.3M	432.7M	497.7M	522.5M
Retained Earnings	(253.9M)	(211.9M)	(148.8M)	(106.8M)	(96.1M)	(100.9M)
Accounts Payable	10.4M	10.5M	15.2M	15.7M	18.1M	10.4M
Cash	100.0M	585.6M	104.1M	153.3M	176.3M	117.4M
Non Current Assets Total	622.9M	1.2B	1.2B	1.1B	1.2B	1.3B
Non Currrent Assets Other	74.5M	76.4M	27.2M	36.0M	41.5M	43.5M
Other Assets	290.1M	153.4M	160.3M	1.0	1.15	1.09
Long Term Debt	313.0M	674.5M	655.8M	513.8M	590.9M	620.4M
Cash And Short Term Investments	521.7M	656.4M	288.7M	278.6M	320.4M	237.8M
Net Receivables	53.0M	96.3M	98.4M	105.6M	121.4M	127.5M
Common Stock Shares Outstanding	43.7M	45.6M	46.5M	52.0M	59.8M	35.9M
Short Term Investments	421.7M	70.8M	184.5M	125.3M	144.1M	137.9M
Liabilities And Stockholders Equity	1.3B	2.1B	1.7B	1.6B	1.8B	1.9B
Non Current Liabilities Total	401.5M	823.8M	758.4M	606.9M	697.9M	732.8M
Inventory	64.7M	98.6M	96.1M	104.4M	120.0M	126.0M
Other Current Assets	12.3M	29.4M	15.2M	21.5M	24.7M	26.0M
Other Stockholder Equity	873.2M	942.1M	924.1M	976.6M	1.1B	599.8M
Total Liab	654.8M	1.3B	906.2M	704.3M	809.9M	850.4M
Property Plant And Equipment Gross	211.2M	264.8M	254.4M	370.3M	425.8M	447.1M
Total Current Assets	651.6M	866.0M	498.3M	510.0M	586.5M	331.8M
Accumulated Other Comprehensive Income	318K	167K	(380K)	247K	284.1K	298.3K
Short Term Debt	157.1M	382.6M	51.9M	17.4M	20.1M	19.1M
Intangible Assets	96.5M	624.0M	540.5M	483.3M	555.7M	583.5M
Common Stock	42K	44K	45K	46K	52.9K	35.1K
Property Plant Equipment	104.7M	136.7M	264.8M	254.4M	292.5M	307.2M
Short Long Term Debt Total	541.1M	1.1B	763.4M	586.0M	674.0M	348.5M
Net Tangible Assets	151.0M	423.6M	(38.7M)	71.2M	81.9M	77.8M
Retained Earnings Total Equity	(388.2M)	(399.4M)	(253.9M)	(211.9M)	(190.7M)	(200.2M)
Capital Surpluse	709.7M	754.0M	873.2M	942.1M	1.1B	685.2M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

CRM	Salesforce
C	Citigroup
GM	General Motors

Additional Tools for Pacira Stock Analysis

When running Pacira BioSciences,'s price analysis, check to measure Pacira BioSciences,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pacira BioSciences, is operating at the current time. Most of Pacira BioSciences,'s value examination focuses on studying past and present price action to predict the probability of Pacira BioSciences,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pacira BioSciences,'s price. Additionally, you may evaluate how the addition of Pacira BioSciences, to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Pacira Historical Balance Sheet

Pacira BioSciences, Inventory

126.01 Million

About Pacira Balance Sheet Analysis

Pacira BioSciences, Balance Sheet Chart

Total Assets

Total Current Liabilities

Total Stockholder Equity

Accounts Payable

Pacira BioSciences, balance sheet Correlations

Pacira BioSciences, Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Pacira BioSciences, balance sheet Accounts

Also Currently Popular

Additional Tools for Pacira Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Non Current Liabilities Total	+ 1.0	Long Term Debt
Property Plant And Equipment Net	+ 0.99	Total Assets
Net Receivables	+ 0.99	Total Stockholder Equity
Property Plant And Equipment Gross	+ 0.99	Total Stockholder Equity
Non Current Assets Total	+ 0.98	Total Assets
Non Current Liabilities Total	+ 0.98	Total Assets

Short Term Investments	- 0.39	Retained Earnings
Common Stock Total Equity	- 0.25	Retained Earnings
Common Stock Shares Outstanding	- 0.12	Retained Earnings
Cash And Short Term Investments	- 0.11	Retained Earnings
Retained Earnings	- 0.06	Current Deferred Revenue
Short Term Investments	- 0.06	Other Liab